# Implantable Provider Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/implantable-provider-group

- Industry: Medical Devices & Equipment
- Headquarters: Alpharetta, US
- Website: www.ipg.com
- Total disclosed funding: $18M
- Latest round: Series C (Aug 19, 2013)
- Investors on record: 3

## About

Implantable Provider Group, Inc. specializes in surgical management solutions, enhancing the quality and affordability of surgical care while focusing on cost-effective procedures within appropriate healthcare settings.Implantable Provider Group, Inc., founded in 2004 and headquartered in Alpharetta, US, is dedicated to optimizing surgical care management. The company was acquired by Evolent Health, LLC in June 2022 for USD 375 mn, which is aimed at expanding their portfolio and customer base. Vince Coppola currently leads the company as CEO, following its strategic pivot under Evolent's ownership.Implantable Provider Group, Inc. offers surgical management solutions focused on improving device selection and shifting surgical procedures to lower-cost, high-quality facilities like ambulatory surgery centers (ASCs). Their services are designed to support health plans, surgeons, and device manufacturers in delivering value-based care. The company operates across various markets, primarily in the United States, aiming to optimize surgical interventions and improve patient outcomes.Implantable Provider Group, Inc. generates revenue through partnerships with health plans and healthcare facilities via fee-for-service agreements and value-based contracts. They receive compensation for managing surgical procedures efficiently, aligning incentives among all stakeholders involved. While specific pricing is not disclosed, the company’s collaborative approach fosters ongoing partnerships, contributing to its revenue model.Following the recent acquisition by Evolent Health, LLC, Implantable Provider Group, Inc. plans to leverage the USD 375 mn funding for operational expansion and the introduction of new surgical management products. The acquisition is expected to close before August 1, 2022, facilitating expansion into additional market segments and enhancing their service portfolio to attract new customers and diversify revenue streams.

## Funding rounds

- Series C, Aug 19, 2013, $10M — Hong Shan, Camden Partners
- Series A, Jul 1, 2007, $8M — Fulcrum Equity Partners

## Investors

- Fulcrum Equity Partners (https://capitalatlas.ai/funds/fulcrum-equity-partners) — Series A
- Hong Shan — Series C
- Camden Partners (https://capitalatlas.ai/funds/camden-partners) — Series C